Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

Researchers discover how type 2 diabetes drug metformin actually works

Researchers from St. Vincent's Institute of Medical Research in Melbourne, Australia, in collaboration with researchers at McMaster University in Canada, are reportedly the first to discover how the type 2 diabetes drug metformin actually works, providing a molecular understanding that could lead to the development of more effective therapies. Mass spectrometry technologies from AB SCIEX, a global leader in analytical technologies, played a critical role in the analysis that led to this breakthrough finding.

25 Nov 2013

EC approves INVOKANA (canagliflozin) medication for adults with type 2 diabetes mellitus

Janssen-Cilag International NV announced today that the European Commission has approved INVOKANA (canagliflozin) in the European Union for the treatment of adults with type 2 diabetes mellitus, to improve glycaemic control[1]. Canagliflozin is an oral, once-daily medication, which belongs to a new class of medications called sodium glucose co-transporter 2 (SGLT2) inhibitors.

23 Nov 2013

Nanotechnology-based technique: A painless method for maintaining healthy blood sugar levels

A new nanotechnology-based technique for regulating blood sugar in diabetics may give patients the ability to release insulin painlessly using a small ultrasound device, allowing them to go days between injections - rather than using needles to give themselves multiple insulin injections each day.

22 Nov 2013

Targeting single enzyme in the obese could help prevent and treat diabetes

A single overactive enzyme worsens the two core defects of diabetes—impaired insulin sensitivity and overproduction of glucose—suggesting that a drug targeting the enzyme could help correct both at once, according to mouse studies done by researchers at Columbia University Medical Center. The findings were published today in the online edition of Cell Metabolism.

22 Nov 2013

Type 2 diabetes cytokine elevation places teeth at risk

Scientists have detected significant differences in the cytokine and chemokine make up of gingival crevicular fluid taken from chronic periodontitis patients with uncontrolled Type 2 diabetes and those without.

21 Nov 2013

Unemployed men show signs of faster ageing in their DNA

Men who are unemployed for more than two years show signs of faster ageing in their DNA, a new study has found.

21 Nov 2013

Voxiva launches new mobile app for Care4life Diabetes self-management program

Voxiva, Inc. announces the launch of a new mobile app for its Care4life(SM) Diabetes self-management program. Care4life provides personalized diabetes education and support using highly credible content, evidence-based behavior change methods, and personalized communications to engage and support people with type 2 diabetes.

21 Nov 2013

People who consume nuts daily are 20% less likely to die

In the largest study of its kind, people who ate a daily handful of nuts were 20 percent less likely to die from any cause over a 30-year period than were those who didn't consume nuts, say scientists from Dana-Farber Cancer Institute, Brigham and Women's Hospital, and the Harvard School of Public Health.

21 Nov 2013

Chronic diseases account for increasing proportion of GPs' workload

GPs in Australia are working three hours less per week in direct clinical care, however they are dealing with more health problems per visit, research led by the University of Sydney shows.

19 Nov 2013

New $3.4 million NIH grant to fund artificial pancreas projects

A high-tech project to turn an ordinary smart phone into an artificial pancreas that could transform the lives of people with type 1 diabetes has received a $3.4 million grant from the National Institutes of Health.

19 Nov 2013

Philipp E. Scherer honored with 15th Naomi Berrie Award for Outstanding Research in Diabetes

Columbia University Medical Center has honored Philipp E. Scherer, PhD, with the 15th Naomi Berrie Award for Outstanding Research in Diabetes, for his work that helped usher in a new understanding of fat and its role in diabetes and other metabolic diseases. His discovery of adiponectin, a hormone produced by fat, helped transform the scientific concept of fat as an inert storage depot to one of it as an endocrine "organ" that exerts control over the brain, muscles, and other organs. The award, given annually by CUMC's Naomi Berrie Diabetes Center, is Columbia's top honor for excellence in diabetes research.

19 Nov 2013

Researchers update promising strategies and therapies to restore skeletal muscle health

The progressive loss of skeletal muscle during aging, known as sarcopenia, underlies limitations in physical function and mobility, which in turn lead to falls, loss of independence, institutionalization and even death.

16 Nov 2013

New smartphone app aims to help diabetic young people keep safe when drinking alcohol

A free smartphone application (app) aimed at younger people, which puts important information about the condition in their hands wherever they are, has notched up more than 1,100 downloads in its first year.

16 Nov 2013

Scientists receive $2.2M grant to improve treatments for immune disorders, inflammatory diseases

Scientists from the Walter and Eliza Hall Institute have been awarded more than $2.2 million from the Australian Research Council (ARC) to improve treatments for immune disorders and inflammatory diseases.

16 Nov 2013

Former status as elite athlete reduces risk of type 2 diabetes later in life

A study of almost 400 former elite male athletes shows that former status as an elite athlete reduces the risk of developing type 2 diabetes in later life by 28%. The research appears in Diabetologia, the journal of the European Association for the Study of Diabetes, and is by Dr Merja Laine, University of Helsinki, Helsinki, Finland, and colleagues.

16 Nov 2013

Patients who undergo gastric bypass less likely to have risk of heart attack and stroke

New research from the Cleveland Clinic shows most patients with diabetes and obesity who undergo gastric bypass not only experience remission of their diabetes and lose significant weight, but they also reduce their risk of having a heart attack by 40 percent and their risk for suffering a stroke by 42 percent, over a 10-year time horizon.

16 Nov 2013

MGH investigators identify molecule that plays key role in the breakdown of kidney filter

One of the most devastating side effects of diabetes is kidney failure, and one of the earliest signs of kidney damage is a disruption of the organ's filtering capacity. Diabetes patients who develop kidney failure must go on dialysis, seriously limiting their quality of life and placing them at significantly increased risk of death. The incidence of kidney disease is increasing with rising rates of obesity-associated type 2 diabetes, but very little progress has been made towards protecting the kidney's filter barrier during the past 50 years.

16 Nov 2013

Study: Surgical weight loss may be able to reverse the effects of aging

Stanford University researchers say surgical weight loss may turn back the effects of aging at a genetic level, in the first study* of its kind presented here during ObesityWeek 2013, the largest international event focused on the basic science, clinical application and prevention and treatment of obesity.

16 Nov 2013

Good quality care for young people with type-1 diabetes unevenly distributed in Ireland

New research launched today to coincide with World Diabetes Day which takes place tomorrow, 14th November 2013 revealed that good quality care for young people with type-1 diabetes is unevenly distributed throughout Ireland.

15 Nov 2013

Diabetes people with low levels of physical activity are at greater risk of cardiovascular disease

The risk of cardiovascular complications in people with type 2 diabetes is directly related to the frequency and duration of physical exercise, according to results of a large follow-up study reported today on World Diabetes Day. Notably, those with low levels of physical activity had a 70% greater risk of cardiovascular death than those with higher levels.

15 Nov 2013

Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

Researchers discover how type 2 diabetes drug metformin actually works

EC approves INVOKANA (canagliflozin) medication for adults with type 2 diabetes mellitus

Nanotechnology-based technique: A painless method for maintaining healthy blood sugar levels

Targeting single enzyme in the obese could help prevent and treat diabetes

Type 2 diabetes cytokine elevation places teeth at risk

Unemployed men show signs of faster ageing in their DNA

Voxiva launches new mobile app for Care4life Diabetes self-management program

People who consume nuts daily are 20% less likely to die

Chronic diseases account for increasing proportion of GPs' workload

New $3.4 million NIH grant to fund artificial pancreas projects

Philipp E. Scherer honored with 15th Naomi Berrie Award for Outstanding Research in Diabetes

Researchers update promising strategies and therapies to restore skeletal muscle health

New smartphone app aims to help diabetic young people keep safe when drinking alcohol

Scientists receive $2.2M grant to improve treatments for immune disorders, inflammatory diseases

Former status as elite athlete reduces risk of type 2 diabetes later in life

Patients who undergo gastric bypass less likely to have risk of heart attack and stroke

MGH investigators identify molecule that plays key role in the breakdown of kidney filter

Study: Surgical weight loss may be able to reverse the effects of aging

Good quality care for young people with type-1 diabetes unevenly distributed in Ireland

Diabetes people with low levels of physical activity are at greater risk of cardiovascular disease

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in